The	O
semaphorin	O
7A	O
receptor	O
Plexin	O
C1	O
is	O
lost	O
during	O
melanoma	B-Cancer
metastasis	O
.	O

The	O
transformation	O
of	O
normal	O
melanocytes	B-Cell
,	O
or	O
melanocyte	B-Cell
stem	I-Cell
cells	I-Cell
,	O
to	O
melanoma	B-Cancer
,	O
is	O
a	O
complex	O
process	O
involving	O
multiple	O
mechanisms	O
.	O

Loss	O
of	O
tumor	B-Cancer
suppressor	O
proteins	O
,	O
which	O
function	O
as	O
brakes	O
on	O
cell	B-Cell
growth	O
,	O
migration	O
,	O
or	O
cell	B-Cell
survival	O
,	O
was	O
recognized	O
early	O
on	O
as	O
an	O
important	O
mechanism	O
for	O
initiation	O
and	O
progression	O
of	O
melanoma	B-Cancer
.	O

Semaphorins	O
and	O
their	O
cognate	O
receptors	O
,	O
Plexins	O
and	O
neuropilins	O
,	O
are	O
involved	O
in	O
neuronal	B-Cell
pathfinding	O
,	O
immune	O
function	O
,	O
and	O
tumor	B-Cancer
progression	O
through	O
effects	O
on	O
blood	B-Multi-tissue_structure
vessel	I-Multi-tissue_structure
growth	O
and	O
cell	B-Cell
migration	O
.	O

Semaphorin	O
7A	O
(	O
Sema7A	O
)	O
is	O
a	O
membrane	B-Cellular_component
-	O
linked	O
semaphorin	O
that	O
is	O
expressed	O
by	O
human	O
keratinocytes	B-Cell
,	O
and	O
we	O
have	O
shown	O
that	O
Sema7A	O
binds	O
to	O
human	O
melanocytes	B-Cell
through	O
beta1	O
-	O
integrins	O
and	O
the	O
Plexin	O
C1	O
receptor	O
.	O

Functional	O
studies	O
showed	O
that	O
Sema7A	O
stimulates	O
cytoskeletal	B-Cellular_component
reorganization	O
in	O
human	O
melanocytes	B-Cell
,	O
resulting	O
in	O
adhesion	O
and	O
dendrite	B-Cellular_component
formation	O
.	O

Downstream	O
targets	O
of	O
Plexin	O
C1	O
signaling	O
in	O
human	O
melanocytes	B-Cell
include	O
cofilin	O
and	O
LIM	O
kinase	O
II	O
,	O
both	O
of	O
which	O
are	O
critical	O
mediators	O
of	O
cell	B-Cell
adhesion	O
and	O
migration	O
.	O

In	O
this	O
report	O
,	O
we	O
analyzed	O
the	O
expression	O
of	O
Plexin	O
C1	O
using	O
immunohistochemistry	O
on	O
sections	B-Cancer
of	O
primary	B-Cancer
and	O
matched	O
metastatic	B-Cancer
lesions	I-Cancer
from	O
19	O
subjects	O
and	O
in	O
a	O
large	O
melanoma	B-Cancer
tumor	I-Cancer
microarray	O
.	O

Our	O
data	O
show	O
a	O
significant	O
loss	O
of	O
Plexin	O
C1	O
in	O
metastatic	B-Cancer
melanoma	I-Cancer
compared	O
with	O
primary	B-Cancer
melanoma	I-Cancer
,	O
suggesting	O
the	O
possibility	O
that	O
the	O
Plexin	O
C1	O
receptor	O
is	O
a	O
tumor	B-Cancer
suppressor	O
protein	O
for	O
melanoma	B-Cancer
.	O

